Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Nautilus Biotechnology, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues0.00.00.00.0
Cost of goods sold0.00.00.010.1
Gross profit0.00.00.0-10.1
Research and development37.729.412.4 
General and administrative25.921.13.31.6
EBIT-63.6-50.5-15.5-9.1
Pre-tax income-57.9-50.3-15.6-9.6
Income taxes0.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%
Net income-57.9-50.3-15.6-9.6
 
Diluted EPS($0.46)($0.60)($0.54)($1.59)
Shares outstanding (diluted)124.684.529.16.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy